Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cancer Head and Neck Cancer' returned 212 results - Page 1 of 11  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Viral Therapy of Cancer Cancer Chemotherapy: Basic Science to the Clinic   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Head and Neck Cancer Drug Pipeline Update 2011   Bioseeker, Feb 2011 There are today 125 (111) companies plus partners developing 134 (118) drugs targeting head and neck cancer in development. In addition, the accumulated number of ceased drugs over the last years European Head and Neck Cancer Therapeutics Markets   Frost & Sullivan, Aug 2007, Pages: 124 This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market. In this research, Frost Global Head and Neck Cancer Drug Pipeline Capsule - 2012   Fore Pharma, Jan 2012, Pages: 13 Fore Pharma’s latest report ‘Global Head and Neck Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global head and neck cancer drug Global Head and Neck Cancer Drug Pipeline Capsule - 2011   Fore Pharma, Aug 2011, Pages: 13 Fore Pharma’s latest report ‘Global Head and Neck Cancer Drug Pipeline Capsule – 2011’ is an outline of all the key research and development (R&D) activities of the global head and neck cancer drug Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016   GlobalData, Jan 2010, Pages: 51 Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 Summary GlobalData, the industry analysis specialist, has released its new report, “Head and Neck Cancer - Drug Pipeline Head and Neck Cancer Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 497 Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline status of head and neck Head and Neck Cancer Global Clinical Trials Review, H2, 2011   GlobalData, Dec 2011, Pages: 123 Head and Neck Cancer Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, H2, 2011" provides data on the Head Head and Neck Cancer Global Clinical Trials Review, Q4, 2010   GlobalData, Dec 2010, Pages: 94 Head and Neck Cancer Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Head and Neck Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Head and Neck Head And Neck Cancer - Pipeline Review, H2 2011   Global Markets Direct, Sep 2011, Pages: 280 Head And Neck Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Head and Neck Cancer - Pipeline Review, H2 2011', provides an overview of the Head and Neck Cancer therapeutic Head And Neck Cancer - Pipeline Review, Q4 2010   Global Markets Direct, Dec 2010, Pages: 235 Head And Neck Cancer - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Head and Neck Cancer Pipeline Review, Q4 2010”, provides an overview of the Head and Neck Cancer therapeutic Head And Neck Cancer - Pipeline Review, Q1 2011   Global Markets Direct, Feb 2011, Pages: 241 Head And Neck Cancer - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Head and Neck Cancer - Pipeline Review, Q1 2011', provides an overview of the Head and Neck Cancer therapeutic Eli Lilly Drops Plans to Seek Approval For its Established Drug Alimta as a Treatment For Head And Neck Cancer   GlobalData, Nov 2010, Pages: 5 Eli Lilly Drops Plans to Seek Approval For its Established Drug Alimta as a Treatment For Head And Neck Cancer Summary Our report, “Eli Lilly Drops Plans to Seek Approval For its Established Drug Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid   Datamonitor, July 2008, Pages: 328 ; Genentech/Roche) therapy. Vectibix (panitumumab; Amgen) and zalutumumab (HuMax-EGFR; Genmab/Medarex) show great promise to compete with Erbitux in the head and neck cancer market, particularly due Phase I/II Trial Head and Neck Cancer Data Update Call - Oncolytics Biotech, Inc., - Earnings Transcript   FactSet, June 2010 Phase I/II Trial Head and Neck Cancer Data Update Call - Oncolytics Biotech, Inc., - Earnings Transcript Monday, June 07, 2010 01:00 Corrected Transcripts are verbatim transcripts that have been Prognosis in Head and Neck Cancer   Informa Healthcare, Dec 2005, Pages: 424 Research on the factors that determine the course and prognosis of head and neck cancers has now reached the stage where a synoptic review is in order, to draw together those aspects Head and Neck Cancer. Emerging Perspectives   Elsevier Science and Technology, Jan 2003, Pages: 602 , Scott. Head and Neck Cancer. Emerging Perspectives Chinese Markets for Cancer Treatment Drugs   AMID Co., July 2010, Pages: 231 Antibiotics Hormone Species Others Western Cancer Treatment Drugs Output and Demand for Kinds of Cancer Head-neck Cancers Respiratory System Cancers Digestive System Cancers Drainage System Cancers Bones Future Oncology   New MEdicine Inc., Feb 2012 INDICATIONS AND TARGETING APPROACHES ErbB RECEPTORS ASSOCIATION BY CANCER INDICATION EPIDERMAL GROWTH FACTOR RECEPTOR (EGFr) -Colorectal Cancer -Head and Neck Cancer -Lung Cancer -Prostate Cancer Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development   GBI Research, Dec 2011, Pages: 215 indications, which includes breast cancer, colorectal cancer, Non-Hodgkin’s lymphoma (NHL), Non-Small Cell Lung Cancer (NSCLC), prostate cancer, ovarian cancer, cervical cancer and head and neck cancer Individualizing and Monitoring Cancer Therapy   Future Medicine Ltd, Aug 2010, Pages: 92 in head and neck cancer, gene mutation in colorectal and non-small cell lung cancer, and epigenetic aberrations. EDITORIAL: - Today’s discoveries to tomorrow’s care: cancer biomarkers revisited CJ Rosser Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network